Search

everythinglearnresearchcommunity

for

Search:↓

Hair problems can be caused by genetics or the environment, and treatment should focus on the cause and reducing hair damage.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Minoxidil improves blood flow and vessel flexibility, potentially helping with vascular stiffness.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Some people with heavy hair shedding might actually have a hidden form of alopecia, which can be identified by specific hair changes.

PI3K/Akt pathway is crucial for hair growth and regeneration.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Some stem cells in the body rarely divide, which could help create better treatments for diseases and aging.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

Understanding chaos and control mechanisms in disease can improve diagnosis and prediction in medicine.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

SSRIs can cause hair loss, especially sertraline, with higher risk in women.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

Substance from human umbilical cord blood cells promotes hair growth.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.